Boston Scientific Forecasts 2024 Adjusted EPS Of $2.45-$2.47 Versus Prior Guidance Of $2.38-$2.42 And Consensus Of $2.41
Portfolio Pulse from Benzinga Newsdesk
Boston Scientific has raised its 2024 adjusted EPS guidance to $2.45-$2.47, surpassing prior guidance and consensus estimates. The company also forecasts significant net sales growth for the year.
October 23, 2024 | 10:34 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Boston Scientific has increased its 2024 adjusted EPS guidance to $2.45-$2.47, higher than previous guidance and consensus. The company also anticipates strong net sales growth.
The upward revision of EPS guidance and strong sales growth forecast are positive indicators for Boston Scientific's financial performance, likely boosting investor confidence and stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100